MétaCan
Menu
← Back to cohort
Record W2789623960 · doi:10.1093/jcag/gwy009.252

A252 METASTASIS TO THE PANCREAS: THE EXPERIENCE OF A HIGH VOLUME HEPATO- PANCREATIC BILLIARY CENTRE

2018· article· en· W2789623960 on OpenAlexaffabout
Stephen A. Taylor, Kuan‐Ming Chiu, Michael F. Byrne, David F. Schaeffer, Fergal Donnellan

Bibliographic record

VenueJournal of the Canadian Association of Gastroenterology · 2018
Typearticle
Languageen
FieldMedicine
TopicPancreatic and Hepatic Oncology Research
Canadian institutionsVancouver General HospitalUniversity of Toronto
Fundersnot available
KeywordsMedicineMalignancyMetastasisPancreasRadiologyAdenocarcinomaFine-needle aspirationEndoscopic ultrasoundPrimary tumorBiopsyCancerInternal medicine

Abstract

fetched live from OpenAlex

Pancreatic metastases (PM) from non-pancreatic primaries are rare, but should be considered in patients with a prior history of malignancy. PM’s represent less than 2% of all pancreatic neoplasms. Studies have not adequately evaluated the ideal oncologic and combined surgical approach for pancreatic metastasis. The aim of this study was to investigate the clinico-pathological presentation of patients with secondary tumors of the pancreas and surgical management. We retrospectively identified patients from a high volume hepato-pancreato-billiary database in Canada dating from January 1989- September 2015. Medical records were retrospectively analyzed for clinical presentation, pathologic details, time period between the diagnosis of the primary tumor to metastasis or disease free interval (DFI), tumor size, focality and surgical resectability. We identified 103 patients (median age 53.5) with disease metastatic to the pancreas for which cytologic material was available via endoscopic ultrasound (EUS) fine needle aspiration (n=49, 47.6%), EUS core biopsy (n=14, 13.6%) or upfront definitive surgical resection (n=38 36.7%). Renal carcinoma was the most common tumor to metastasize to the pancreas (52%), followed by lung carcinoma (10%), colonic adenocarcinoma (10%), melanoma (6%) and breast (6%) followed by 10 other primary tumors. The median DFI was 6.8 years (inter-quartile range 1.23–12.78) between diagnoses of primary malignancy to metastasis. There was a significant difference in DFI for RCC (median 9.7 years, p <0.05) and 4.5 years compared to all other pathologies. 38 (36.7%) patients with a median age of 58.5 (range 33–79) were identified to have pancreatic metastasis amenable to surgical resection. The average size of the metastatic lesions in greatest dimension was 2.6 cm (range: 1.2-7cm) and the majority were a single focus. Open surgical distal pancreatectomy with or without splenectomy was the most common operation (n=10, 26%) followed by pancreaticoduodenectomy (n=9, 23%) and there were no postoperative deaths. The median survival of resected patients captured to follow-up via electronic medical record (n=18) was 31 months (range: 16–87 months). The most common metastatic tumor to the pancreas was identified as RCC, which is in accordance with the literature. Tissue acquisition via EUS is an increasingly useful modality for guiding precision to surgical resection of pancreatic tumors with the ultimate goal of rendering a patient disease free and reducing perioperative morbidity. CAG

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.054
Threshold uncertainty score0.107

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.275
Teacher spread0.260 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueJournal of the Canadian Association of Gastroenterology→Same topicPancreatic and Hepatic Oncology Research→French-language works237,207→